Has the PTAB made a difference in drug settlements and generic entry?

Autor:	Erik, Hovenkamp, Jorge, Lemus, Arti, Rai, Saurabh, Vishnubhakat
Rok vydání:	2022
Předmět:	Drug Industry Biomedical Engineering Drugs Generic Molecular Medicine Bioengineering Applied Microbiology and Biotechnology United States Drug Costs Biotechnology
Zdroj:	Nature Biotechnology. 40:1569-1572
ISSN:	1546-1696 1087-0156
DOI:	10.1038/s41587-022-01526-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e38232bcd0c1fce5220b88649249e58 https://doi.org/10.1038/s41587-022-01526-5 Zobrazit plný text záznamu Full text from SpringerLink